16:15 às 17:15 - Sessão 3 - Best of SABCS 2017 - Parte 2

16:55 às 17:05 - Abstract GS5-06. A U.S. Food and Drug Administration pooled analysis of outcomes of older women with hormone-receptor positive metastatic breast cancer treated with a CDK4/6 inhibitor as initial endocrine based therapy